What is OPCH revenue?

Option Care Health Inc. (OPCH) reported $5.75B of revenue for the twelve months ended Sep 30, 2026. That is up 4.0% from the year before. Revenue for fiscal 2025 was $5.65B.

Yes. Option Care Health Inc. earned $215.19M in net income for the twelve months ended Sep 30, 2026, a net margin of 3.7%.

How much cash and debt does OPCH have?

Option Care Health Inc. reported $299.09M in cash and cash equivalents and $1.16B of debt on its most recent balance sheet in SEC filings.

How fast is OPCH revenue growing?

Option Care Health Inc.'s revenue changed +13.0% in fiscal 2025, to $5.65B. Its compound annual growth rate was +13.3% over 5 years and +19.1% over 10 years.

What is OPCH gross margin?

Option Care Health Inc.'s gross profit was $1.10B on $5.75B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 19.1%.

What is OPCH free cash flow?

Option Care Health Inc. generated $281.65M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $322.10M less capital expenditures.

What is OPCH earnings per share?

Diluted earnings per share were $1.38 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did OPCH last report financial results?

The latest statements here come from Option Care Health Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.

Where does this OPCH financial data come from?

Quantisnow builds these statements from the structured XBRL data Option Care Health Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · OPCH

Option Care Health Inc. (OPCH) financials

For the twelve months ended Sep 30, 2026, Option Care Health Inc. reported $5.75B of revenue and $215.19M of net income.

Revenue, TTM: $5.75B
Revenue growth, YoY: +4.0%
Net income, TTM: $215.19M
Net income growth, YoY: +2.9%
Net margin: 3.7%
Free cash flow, TTM: $281.65M
EPS, diluted, TTM: $1.38
EPS growth, YoY: +8.7%
Cash: $299.09M
Total debt: $1.16B
P/E: 22.03
P/S: 0.82
Market cap: $4.74B

Annual revenue$5.65B

FY2016FY2025

Annual net income$207.59M

FY2016FY2025

Annual free cash flow$217.14M

FY2017FY2025

OPCH revenue and earnings growth

OPCH revenueQ3 2026$1.49B

Quarter YoY: +4.1%
QoQ: +3.5%
FY YoY: +13.0%
5Y CAGR: +13.3%
10Y CAGR: +19.1%

OPCH revenue was $1.49B in fiscal Q3 2026 (ended Sep 30, 2026), up 4.1% from a year earlier and up 3.5% from the prior quarter. For the full fiscal 2025 it was $5.65B, up 13.0% from fiscal 2024. Compound annual growth was +13.3% over 5 years and +19.1% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

OPCH net incomeQ3 2026$57.43M

Quarter YoY: +10.8%
QoQ: +6.5%
FY YoY: -2.0%

OPCH net income was $57.43M in fiscal Q3 2026 (ended Sep 30, 2026), up 10.8% from a year earlier and up 6.5% from the prior quarter. For the full fiscal 2025 it was $207.59M, down 2.0% from fiscal 2024. It rose in 2 of the last 4 fiscal years.

OPCH EPSQ3 2026$0.38

Quarter YoY: +18.8%
QoQ: +8.6%
FY YoY: +3.3%

OPCH diluted EPS was $0.38 in fiscal Q3 2026 (ended Sep 30, 2026), up 18.8% from a year earlier and up 8.6% from the prior quarter. For the full fiscal 2025 it was $1.27, up 3.3% from fiscal 2024.

OPCH free cash flowQ3 2026$108.05M

Quarter YoY: -17.0%
QoQ: -37.4%
FY YoY: -24.5%
5Y CAGR: +16.7%

OPCH free cash flow was $108.05M in fiscal Q3 2026 (ended Sep 30, 2026), down 17.0% from a year earlier and down 37.4% from the prior quarter. For the full fiscal 2025 it was $217.14M, down 24.5% from fiscal 2024. Compound annual growth was +16.7% over 5 years. It rose in 4 of the last 6 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$5.65B	$5.00B	$4.30B	$3.94B	$3.44B	$3.03B	$2.31B	$1.94B	$1.83B	$935.59M
Cost of revenue	$4.56B	$3.99B	$3.32B	$2.56B	$2.66B	$2.35B	$1.80B	$1.52B	$1.38B	$673.51M
Gross profit	$1.09B	$1.01B	$981.22M	$866.92M	$779.61M	$682.26M	$513.00M	$422.21M	$446.00M	$262.08M
Selling, general and admin	$682.45M	$630.25M	$607.43M	$566.12M	$525.71M	$500.20M	$459.63M	$345.88M	$338.46M	$38.80M
Operating income	$337.91M	$321.83M	$314.60M	$240.23M	$190.84M	$110.75M	-$319.0K	$38.27M	$27.28M	-$10.99M
Interest expense	$54.56M	$49.03M	$51.25M	$53.81M	$67.00M	$107.77M	$73.72M	$45.82M	-	-
Pre-tax income	$282.90M	$283.60M	$358.74M	$205.77M	$116.49M	-$5.24M	-$78.19M	-$51.02M	-$67.43M	-$34.16M
Income tax	$75.31M	$71.78M	$91.65M	$55.21M	-$23.40M	$2.83M	-$2.27M	-$2.65M	-$18.59M	$2.02M
Net income	$207.59M	$211.82M	$267.09M	$150.56M	$139.90M	-$8.08M	-$75.92M	-$6.12M	$3.88M	-$42.77M
EPS, basic	$1.28	$1.23	$1.49	$0.83	$0.78	-$0.04	-$0.49	-$0.04	$0.03	-$0.55
EPS, diluted	$1.27	$1.23	$1.48	$0.83	$0.77	-$0.04	-$0.49	-$0.04	$0.03	-$0.55
Diluted shares	163.4M	172.8M	180.4M	182.1M	181.2M	181.0M	156.3M	142.6M	142.6M	93.7M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$232.62M	$412.56M	$343.85M	$294.19M	$119.42M	$99.27M	$67.06M	$36.39M	$53.12M	$44.87M
Receivables	$473.57M	$409.73M	$377.66M	$377.54M	$338.24M	$328.34M	$324.42M	$310.17M	$85.52M	$109.09M
Inventory	$471.15M	$388.13M	$274.00M	$224.28M	$183.09M	$158.60M	$115.88M	$83.34M	$38.04M	$36.16M
Current assets	$1.26B	$1.32B	$1.09B	$994.34M	$710.26M	$657.01M	$558.65M	$467.43M	$186.59M	$173.33M
Goodwill	$1.61B	$1.54B	$1.54B	$1.53B	$1.48B	$1.43B	$1.43B	$632.47M	$627.39M	$365.95M
Total assets	$3.46B	$3.42B	$3.22B	$3.11B	$2.79B	$2.65B	$2.59B	$1.43B	$603.09M	$604.99M
Current liabilities	$829.35M	$780.15M	$618.31M	$565.35M	$459.69M	$434.02M	$330.00M	$240.00M	$105.13M	$130.15M
Short-term debt	$6.78M	$6.51M	$6.00M	$6.00M	$6.00M	$9.25M	$9.25M	$4.15M	$1.72M	$18.52M
Long-term debt	$1.15B	$1.10B	$1.06B	$1.06B	$1.06B	$1.12B	$1.28B	$535.23M	$478.87M	$433.41M
Total debt	$1.16B	$1.11B	$1.06B	$1.06B	$1.07B	$1.12B	$1.29B	$539.38M	$480.59M	$451.93M
Total liabilities	$2.13B	$2.02B	$1.80B	$1.73B	$1.62B	$1.63B	$1.68B	$825.39M	$605.76M	$566.60M
Shareholders' equity	$1.33B	$1.40B	$1.42B	$1.39B	$1.18B	$1.02B	$906.83M	$602.83M	$606.11M	$600.77M

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$258.45M	$323.39M	$371.30M	$267.55M	$208.57M	$127.39M	$39.47M	$24.43M	$37.87M	-$42.54M
Capital expenditures	$41.31M	$35.61M	$41.87M	$35.36M	$25.63M	$26.88M	$28.29M	$26.28M	$24.96M	-
Free cash flow	$217.14M	$287.79M	$329.43M	$232.19M	$182.94M	$100.52M	$11.18M	-$1.85M	$12.91M	-
Investing cash flow	-$161.08M	-$36.47M	-$56.51M	-$108.05M	-$111.54M	-$26.33M	-$727.83M	-$37.00M	-$24.47M	-$73.21M
Financing cash flow	-$277.31M	-$218.21M	-$265.13M	$15.27M	-$76.87M	-$68.85M	$719.02M	-$4.15M	-$5.15M	$109.74M
Share repurchases	$309.95M	$252.73M	$250.26M	$0	$0	-	-	-	-	-
Stock-based compensation	$39.96M	$36.14M	$30.48M	$16.78M	$9.57M	$2.92M	$4.17M	$2.14M	$1.46M	$1.80M
Depreciation and amortization	$67.54M	$60.91M	$59.20M	$60.56M	$63.06M	$71.31M	$53.69M	$38.06M	$34.66M	$22.02M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	13.0%	16.2%	9.1%	14.7%	13.4%	31.3%	19.1%	6.1%	95.4%	-4.7%
Net income growth, YoY	-2.0%	-20.7%	77.4%	7.6%	-	-	-	-	-	-
EPS growth, YoY	3.3%	-16.9%	78.3%	7.8%	-	-	-	-	-	-
Gross margin	19.3%	20.3%	22.8%	22.0%	22.7%	22.5%	22.2%	21.8%	24.4%	28.0%
Operating margin	6.0%	6.4%	7.3%	6.1%	5.5%	3.7%	-0.0%	2.0%	1.5%	-1.2%
Net margin	3.7%	4.2%	6.2%	3.8%	4.1%	-0.3%	-3.3%	-0.3%	0.2%	-4.6%
Free cash flow margin	3.8%	5.8%	7.7%	5.9%	5.3%	3.3%	0.5%	-0.1%	0.7%	-
Return on equity	15.7%	15.1%	18.8%	10.9%	11.9%	-0.8%	-8.4%	-1.0%	0.6%	-7.1%
Return on assets	6.0%	6.2%	8.3%	4.8%	5.0%	-0.3%	-2.9%	-0.4%	0.6%	-7.1%
Current ratio	1.53	1.70	1.77	1.76	1.55	1.51	1.69	1.95	1.77	1.33
Debt to equity	0.88	0.79	0.75	0.77	0.91	1.11	1.42	0.89	0.79	0.75

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$1.49B	$1.44B	$1.35B	$1.47B	$1.44B	$1.42B	$1.33B	$1.35B	$1.28B	$1.23B	$1.15B	$1.12B
Cost of revenue	$1.21B	$1.18B	$1.09B	$1.18B	$1.16B	$1.15B	$1.07B	$1.08B	$1.02B	$977.82M	$907.55M	$877.27M
Gross profit	$284.97M	$267.25M	$262.01M	$282.90M	$272.90M	$269.04M	$263.05M	$268.38M	$256.75M	$249.37M	$238.50M	$247.12M
Selling, general and admin	$177.64M	$164.66M	$174.56M	$172.14M	$172.10M	$170.09M	$168.12M	$164.73M	$157.00M	$153.78M	$154.74M	$147.78M
Operating income	$89.22M	$85.14M	$72.55M	$91.50M	$84.51M	$82.71M	$79.19M	$87.04M	$85.09M	$80.67M	$69.03M	$84.56M
Interest expense	$12.88M	$14.02M	$13.30M	$12.73M	$14.15M	$14.45M	$13.23M	$10.88M	$12.35M	$12.60M	$13.20M	$12.43M
Pre-tax income	$78.90M	$73.99M	$61.00M	$81.52M	$68.97M	$68.86M	$63.56M	$81.05M	$73.55M	$72.04M	$56.95M	$78.92M
Income tax	$21.47M	$20.07M	$15.66M	$23.01M	$17.15M	$18.34M	$16.81M	$20.92M	$19.70M	$19.00M	$12.16M	$21.75M
Net income	$57.43M	$53.91M	$45.34M	$58.50M	$51.82M	$50.52M	$46.74M	$60.13M	$53.86M	$53.04M	$44.79M	$57.18M
EPS, basic	$0.38	$0.35	$0.29	$0.37	$0.32	$0.31	$0.28	$0.34	$0.32	$0.31	$0.26	$0.32
EPS, diluted	$0.38	$0.35	$0.29	$0.36	$0.32	$0.31	$0.28	$0.36	$0.31	$0.30	$0.26	$0.33
Diluted shares	150.5M	153.5M	158.2M	-	163.1M	164.1M	166.8M	-	171.9M	174.1M	175.6M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$299.09M	$193.77M	$177.32M	$232.62M	$309.82M	$198.82M	$171.37M	$412.56M	$483.03M	$376.87M	$219.51M	$343.85M
Receivables	$505.57M	$511.51M	$516.44M	$473.57M	$474.50M	$481.25M	$476.65M	$409.73M	$428.95M	$468.30M	$573.65M	$377.66M
Inventory	$408.05M	$399.61M	$415.69M	$471.15M	$415.72M	$403.54M	$369.03M	$388.13M	$310.60M	$281.42M	$241.95M	$274.00M
Current assets	$1.31B	$1.20B	$1.20B	$1.26B	$1.28B	$1.18B	$1.10B	$1.32B	$1.32B	$1.23B	$1.13B	$1.09B
Goodwill	$1.61B	$1.61B	$1.61B	$1.61B	$1.61B	$1.61B	$1.61B	$1.54B	$1.54B	$1.54B	$1.54B	$1.54B
Total assets	$3.48B	$3.38B	$3.38B	$3.46B	$3.48B	$3.38B	$3.31B	$3.42B	$3.43B	$3.35B	$3.25B	$3.22B
Current liabilities	$850.53M	$819.48M	$729.75M	$829.35M	$823.91M	$773.62M	$713.66M	$780.15M	$763.22M	$695.41M	$636.95M	$618.31M
Short-term debt	$6.78M	$6.78M	$6.78M	$6.78M	$6.78M	$6.51M	$6.51M	$6.51M	$6.51M	$6.51M	$6.00M	$6.00M
Long-term debt	$1.15B	$1.15B	$1.15B	$1.15B	$1.16B	$1.10B	$1.10B	$1.10B	$1.11B	$1.11B	$1.06B	$1.06B
Total debt	$1.16B	$1.16B	$1.16B	$1.16B	$1.16B	$1.11B	$1.11B	$1.11B	$1.11B	$1.11B	$1.06B	$1.06B
Total liabilities	$2.15B	$2.12B	$2.03B	$2.13B	$2.12B	$2.02B	$1.96B	$2.02B	$2.00B	$1.94B	$1.82B	$1.80B
Shareholders' equity	$1.32B	$1.26B	$1.35B	$1.33B	$1.36B	$1.36B	$1.35B	$1.40B	$1.43B	$1.41B	$1.43B	$1.42B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$114.73M	$183.59M	-$12.11M	$35.89M	$139.44M	$90.33M	-$7.21M	$36.12M	$160.40M	$195.66M	-$68.78M	$50.97M
Capital expenditures	$6.68M	$11.08M	$9.05M	$13.65M	$9.20M	$9.10M	$9.37M	$10.34M	$9.67M	$9.78M	$5.82M	$19.89M
Free cash flow	$108.05M	$172.52M	-$21.16M	$22.25M	$130.24M	$81.24M	-$16.59M	$25.78M	$150.73M	$185.88M	-$74.60M	$31.08M
Investing cash flow	-$6.68M	-$11.68M	-$9.32M	-$13.65M	-$11.72M	-$9.02M	-$126.69M	-$11.20M	-$9.67M	-$9.78M	-$5.82M	-$15.78M
Financing cash flow	-$2.72M	-$155.47M	-$33.87M	-$99.44M	-$16.71M	-$53.87M	-$107.29M	-$95.38M	-$44.58M	-$28.52M	-$49.73M	-$77.83M
Share repurchases	$0	-	-	$95.06M	$62.46M	-	-	$92.60M	$42.00M	$78.07M	$40.05M	$75.15M
Stock-based compensation	$9.33M	$8.38M	$10.20M	$9.32M	$11.13M	$10.71M	$8.80M	$8.52M	$10.41M	$7.61M	$9.61M	$7.57M
Depreciation and amortization	$18.12M	$17.45M	$14.91M	$19.26M	$16.29M	$16.24M	$15.75M	$16.61M	$14.66M	$14.91M	$14.73M	$14.78M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	4.1%	1.9%	1.3%	8.8%	12.2%	15.4%	16.3%	19.7%	17.0%	14.8%	12.8%	9.5%
Net income growth, YoY	10.8%	6.7%	-3.0%	-2.7%	-3.8%	-4.8%	4.4%	5.2%	-4.3%	-53.6%	14.2%	20.3%
EPS growth, YoY	18.8%	12.9%	3.6%	0.0%	3.2%	3.3%	7.7%	9.1%	0.0%	-52.4%	23.8%	26.9%
Gross margin	19.1%	18.5%	19.4%	19.3%	19.0%	19.0%	19.7%	19.9%	20.1%	20.3%	20.8%	22.0%
Operating margin	6.0%	5.9%	5.4%	6.2%	5.9%	5.8%	5.9%	6.5%	6.7%	6.6%	6.0%	7.5%
Net margin	3.8%	3.7%	3.4%	4.0%	3.6%	3.6%	3.5%	4.5%	4.2%	4.3%	3.9%	5.1%
Free cash flow margin	7.2%	12.0%	-1.6%	1.5%	9.1%	5.7%	-1.2%	1.9%	11.8%	15.1%	-6.5%	2.8%
Current ratio	1.54	1.47	1.64	1.53	1.56	1.52	1.54	1.70	1.73	1.77	1.77	1.77
Debt to equity	0.87	0.92	0.86	0.88	0.86	0.82	0.82	0.79	0.78	0.79	0.74	0.75

Source: XBRL data Option Care Health Inc. files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

OPCH peers

Company	Revenue	Growth	Net income	Net margin	Market cap
OPCH	$5.75B	+4.0%	$215.19M	3.7%	$4.74B
BTSGBrightSpring Health Services Inc.	$15.25B	+26.0%	$410.27M	2.7%	$13.36B
CHEChemed Corp	$2.66B	+5.2%	$282.40M	10.6%	$6.87B
HIMSHims & Hers Health Inc.	$2.58B	+28.0%	-$142.03M	-5.5%	$6.06B
LFSTLifeStance Health Group Inc.	$1.68B	+22.6%	$71.91M	4.3%	$5.26B
PRVAPrivia Health Group Inc.	$2.43B	+19.2%	$36.08M	1.5%	$3.12B
AVAHAveanna Healthcare Holdings Inc.	$2.60B	+19.5%	$274.76M	10.6%	$2.89B
ADUSAddus HomeCare Corporation	$1.50B	+11.5%	$111.05M	7.4%	$2.32B
WGSGeneDx Holdings Corp.	$454.43M	+25.4%	-$106.36M	-23.4%	$1.86B

OPCH FAQ

9 questions

What is OPCH revenue?
Option Care Health Inc. (OPCH) reported $5.75B of revenue for the twelve months ended Sep 30, 2026. That is up 4.0% from the year before. Revenue for fiscal 2025 was $5.65B.
Is OPCH profitable?
Yes. Option Care Health Inc. earned $215.19M in net income for the twelve months ended Sep 30, 2026, a net margin of 3.7%.
How much cash and debt does OPCH have?
Option Care Health Inc. reported $299.09M in cash and cash equivalents and $1.16B of debt on its most recent balance sheet in SEC filings.
How fast is OPCH revenue growing?
Option Care Health Inc.'s revenue changed +13.0% in fiscal 2025, to $5.65B. Its compound annual growth rate was +13.3% over 5 years and +19.1% over 10 years.
What is OPCH gross margin?
Option Care Health Inc.'s gross profit was $1.10B on $5.75B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 19.1%.
What is OPCH free cash flow?
Option Care Health Inc. generated $281.65M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $322.10M less capital expenditures.
What is OPCH earnings per share?
Diluted earnings per share were $1.38 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did OPCH last report financial results?
The latest statements here come from Option Care Health Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
Where does this OPCH financial data come from?
Quantisnow builds these statements from the structured XBRL data Option Care Health Inc. files with the SEC. It is provided for information only and is not investment advice.